China Furosemide Market Report & Forecast 2021-2027

China Furosemide Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Furosemide Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Furosemide Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Furosemide Overall Market Size
2.1 China Furosemide Market Size: 2021 VS 2027
2.2 China Furosemide Revenue, Prospects & Forecasts: 2016-2027
2.3 China Furosemide Sales: 2016-2027
3 Company Landscape
3.1 Top Furosemide Players in China Market
3.2 Top China Furosemide Companies Ranked by Revenue
3.3 China Furosemide Revenue by Companies
3.4 China Furosemide Sales by Companies
3.5 China Furosemide Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Furosemide Companies in China Market, by Revenue in 2020
3.7 Manufacturers Furosemide Product Type
3.8 Tier 1, Tier 2 and Tier 3 Furosemide Players in China Market
3.8.1 List of Tier 1 Furosemide Companies in China
3.8.2 List of Tier 2 and Tier 3 Furosemide Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Furosemide Market Size Markets, 2021 & 2027
4.1.2 Injection
4.1.3 Solution
4.1.4 Tablet
4.2 By Type - China Furosemide Revenue & Forecasts
4.2.1 By Type - China Furosemide Revenue, 2016-2021
4.2.2 By Type - China Furosemide Revenue, 2022-2027
4.2.3 By Type - China Furosemide Revenue Market Share, 2016-2027
4.3 By Type - China Furosemide Sales & Forecasts
4.3.1 By Type - China Furosemide Sales, 2016-2021
4.3.2 By Type - China Furosemide Sales, 2022-2027
4.3.3 By Type - China Furosemide Sales Market Share, 2016-2027
4.4 By Type - China Furosemide Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Furosemide Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Pharmacy
5.1.4 Clinics
5.1.5 Others
5.2 By Application - China Furosemide Revenue & Forecasts
5.2.1 By Application - China Furosemide Revenue, 2016-2021
5.2.2 By Application - China Furosemide Revenue, 2022-2027
5.2.3 By Application - China Furosemide Revenue Market Share, 2016-2027
5.3 By Application - China Furosemide Sales & Forecasts
5.3.1 By Application - China Furosemide Sales, 2016-2021
5.3.2 By Application - China Furosemide Sales, 2022-2027
5.3.3 By Application - China Furosemide Sales Market Share, 2016-2027
5.4 By Application - China Furosemide Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Sanofi Aventis
6.1.1 Sanofi Aventis Corporation Information
6.1.2 Sanofi Aventis Overview
6.1.3 Sanofi Aventis Furosemide Sales and Revenue in China Market (2016-2021)
6.1.4 Sanofi Aventis Furosemide Product Description
6.1.5 Sanofi Aventis Recent Developments
6.2 US Pharm Holdings
6.2.1 US Pharm Holdings Corporation Information
6.2.2 US Pharm Holdings Overview
6.2.3 US Pharm Holdings Furosemide Sales and Revenue in China Market (2016-2021)
6.2.4 US Pharm Holdings Furosemide Product Description
6.2.5 US Pharm Holdings Recent Developments
6.3 Mylan
6.3.1 Mylan Corporation Information
6.3.2 Mylan Overview
6.3.3 Mylan Furosemide Sales and Revenue in China Market (2016-2021)
6.3.4 Mylan Furosemide Product Description
6.3.5 Mylan Recent Developments
6.4 Sandoz
6.4.1 Sandoz Corporation Information
6.4.2 Sandoz Overview
6.4.3 Sandoz Furosemide Sales and Revenue in China Market (2016-2021)
6.4.4 Sandoz Furosemide Product Description
6.4.5 Sandoz Recent Developments
6.5 Hospira
6.5.1 Hospira Corporation Information
6.5.2 Hospira Overview
6.5.3 Hospira Furosemide Sales and Revenue in China Market (2016-2021)
6.5.4 Hospira Furosemide Product Description
6.5.5 Hospira Recent Developments
6.6 West-Ward Pharms
6.6.1 West-Ward Pharms Corporation Information
6.6.2 West-Ward Pharms Overview
6.6.3 West-Ward Pharms Furosemide Sales and Revenue in China Market (2016-2021)
6.6.4 West-Ward Pharms Furosemide Product Description
6.6.5 West-Ward Pharms Recent Developments
6.7 Ivax Sub Teva Pharms
6.7.1 Ivax Sub Teva Pharms Corporation Information
6.7.2 Ivax Sub Teva Pharms Overview
6.7.3 Ivax Sub Teva Pharms Furosemide Sales and Revenue in China Market (2016-2021)
6.7.4 Ivax Sub Teva Pharms Furosemide Product Description
6.7.5 Ivax Sub Teva Pharms Recent Developments
6.8 Emcure Pharms
6.8.1 Emcure Pharms Corporation Information
6.8.2 Emcure Pharms Overview
6.8.3 Emcure Pharms Furosemide Sales and Revenue in China Market (2016-2021)
6.8.4 Emcure Pharms Furosemide Product Description
6.8.5 Emcure Pharms Recent Developments
6.9 Sun Pharm Inds
6.9.1 Sun Pharm Inds Corporation Information
6.9.2 Sun Pharm Inds Overview
6.9.3 Sun Pharm Inds Furosemide Sales and Revenue in China Market (2016-2021)
6.9.4 Sun Pharm Inds Furosemide Product Description
6.9.5 Sun Pharm Inds Recent Developments
7 China Furosemide Production Capacity, Analysis
7.1 China Furosemide Production Capacity, 2016-2027
7.2 Furosemide Production Capacity of Key Manufacturers in China Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Furosemide Supply Chain Analysis
9.1 Furosemide Industry Value Chain
9.2 Furosemide Upstream Market
9.3 Furosemide Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Furosemide Distributors and Sales Agents in China Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Furosemide in China Market
Table 2. Top Furosemide Players in China Market, Ranking by Revenue (2019)
Table 3. China Furosemide Revenue by Companies, (US$, Mn), 2016-2021
Table 4. China Furosemide Revenue Share by Companies, 2016-2021
Table 5. China Furosemide Sales by Companies, (MT), 2016-2021
Table 6. China Furosemide Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Furosemide Price (2016-2021) & (USD/Kg)
Table 8. Manufacturers Furosemide Product Type
Table 9. List of Tier 1 Furosemide Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Furosemide Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Injection
Table 12. Major Manufacturers of Solution
Table 13. By Type - China Furosemide Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - China Furosemide Revenue (US$, Mn), 2016-2021
Table 15. By Type - China Furosemide Revenue (US$, Mn), 2022-2027
Table 16. By Type - China Furosemide Sales (MT), 2016-2021
Table 17. By Type - China Furosemide Sales (MT), 2022-2027
Table 18. By Application - China Furosemide Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - China Furosemide Revenue (US$, Mn), 2016-2021
Table 20. By Application - China Furosemide Revenue (US$, Mn), 2022-2027
Table 21. By Application - China Furosemide Sales (MT), 2016-2021
Table 22. By Application - China Furosemide Sales (MT), 2022-2027
Table 23. Sanofi Aventis Corporation Information
Table 24. Sanofi Aventis Description and Major Businesses
Table 25. Sanofi Aventis Furosemide Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 26. Sanofi Aventis Furosemide Product
Table 27. Sanofi Aventis Recent Developments
Table 28. US Pharm Holdings Corporation Information
Table 29. US Pharm Holdings Description and Major Businesses
Table 30. US Pharm Holdings Furosemide Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 31. US Pharm Holdings Furosemide Product
Table 32. US Pharm Holdings Recent Developments
Table 33. Mylan Corporation Information
Table 34. Mylan Description and Major Businesses
Table 35. Mylan Furosemide Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 36. Mylan Furosemide Product
Table 37. Mylan Recent Developments
Table 38. Sandoz Corporation Information
Table 39. Sandoz Description and Major Businesses
Table 40. Sandoz Furosemide Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 41. Sandoz Furosemide Product
Table 42. Sandoz Recent Developments
Table 43. Hospira Corporation Information
Table 44. Hospira Description and Major Businesses
Table 45. Hospira Furosemide Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 46. Hospira Furosemide Product
Table 47. Hospira Recent Developments
Table 48. West-Ward Pharms Corporation Information
Table 49. West-Ward Pharms Description and Major Businesses
Table 50. West-Ward Pharms Furosemide Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 51. West-Ward Pharms Furosemide Product
Table 52. West-Ward Pharms Recent Developments
Table 53. Ivax Sub Teva Pharms Corporation Information
Table 54. Ivax Sub Teva Pharms Description and Major Businesses
Table 55. Ivax Sub Teva Pharms Furosemide Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 56. Ivax Sub Teva Pharms Furosemide Product
Table 57. Ivax Sub Teva Pharms Recent Developments
Table 58. Emcure Pharms Corporation Information
Table 59. Emcure Pharms Description and Major Businesses
Table 60. Emcure Pharms Furosemide Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 61. Emcure Pharms Furosemide Product
Table 62. Emcure Pharms Recent Developments
Table 63. Sun Pharm Inds Corporation Information
Table 64. Sun Pharm Inds Description and Major Businesses
Table 65. Sun Pharm Inds Furosemide Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 66. Sun Pharm Inds Furosemide Product
Table 67. Sun Pharm Inds Recent Developments
Table 68. Furosemide Production Capacity (MT) of Key Manufacturers in China Market, 2019-2021 (MT)
Table 69. China Furosemide Capacity Market Share of Key Manufacturers, 2019-2021
Table 70. Furosemide Market Opportunities & Trends in China Market
Table 71. Furosemide Market Drivers in China Market
Table 72. Furosemide Market Restraints in China Market
Table 73. Furosemide Raw Materials
Table 74. Furosemide Raw Materials Suppliers in China Market
Table 75. Typical Furosemide Downstream
Table 76. Furosemide Downstream Clients in China Market
Table 77. Furosemide Distributors and Sales Agents in China Market
List of Figures
Figure 1. Furosemide Product Picture
Figure 2. Furosemide Segment by Type
Figure 3. Furosemide Segment by Application
Figure 4. China Furosemide Market Overview: 2020
Figure 5. China Furosemide Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. China Furosemide Revenue, 2016-2027 (US$, Mn)
Figure 7. Furosemide Sales in China Market: 2016-2027 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Furosemide Revenue in 2020
Figure 9. Injection Product Picture
Figure 10. Solution Product Picture
Figure 11. Tablet Product Picture
Figure 12. By Type - China Furosemide Sales Market Share, 2016-2027
Figure 13. By Type - China Furosemide Revenue Market Share, 2016-2027
Figure 14. By Type - China Furosemide Price (USD/Kg), 2016-2027
Figure 15. Hospital
Figure 16. Pharmacy
Figure 17. Clinics
Figure 18. Others
Figure 19. By Application - China Furosemide Sales Market Share, 2016-2027
Figure 20. By Application - China Furosemide Revenue Market Share, 2016-2027
Figure 21. By Application - China Furosemide Price (USD/Kg), 2016-2027
Figure 22. Sanofi Aventis Furosemide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. US Pharm Holdings Furosemide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Mylan Furosemide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Sandoz Furosemide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Hospira Furosemide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. West-Ward Pharms Furosemide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Ivax Sub Teva Pharms Furosemide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Emcure Pharms Furosemide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Sun Pharm Inds Furosemide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. China Furosemide Production Capacity (MT), 2016-2027
Figure 32. Furosemide Industry Value Chain
Figure 33. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs